Annual Operating Margin
20.92%
+4.19%+25.04%
31 December 2023
Summary:
Neurocrine Biosciences annual operating profit margin is currently 20.92%, with the most recent change of +4.19% (+25.04%) on 31 December 2023. During the last 3 years, it has fallen by -10.39% (-33.18%). NBIX annual operating margin is now -52.26% below its all-time high of 43.82%, reached on 31 December 2011.NBIX Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Margin
29.71%
+4.65%+18.56%
30 September 2024
Summary:
Neurocrine Biosciences quarterly operating profit margin is currently 29.71%, with the most recent change of +4.65% (+18.56%) on 30 September 2024. Over the past year, it has increased by +1.40% (+4.95%). NBIX quarterly operating margin is now -59.36% below its all-time high of 73.11%, reached on 30 September 2011.NBIX Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Operating Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.0% | +5.0% |
| 3 y3 years | -33.2% | +97.7% |
| 5 y5 years | +126.9% | -26.8% |
NBIX Operating Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -33.2% | +25.0% | at high | +2871.0% |
| 5 y | 5 years | -33.2% | +126.9% | -26.8% | +2871.0% |
| alltime | all time | -52.3% | +100.1% | -59.4% | +100.0% |
Neurocrine Biosciences Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 29.71%(+18.6%) |
| June 2024 | - | 25.06%(+22.7%) |
| Mar 2024 | - | 20.43%(-30.0%) |
| Dec 2023 | 20.92%(+25.0%) | 29.17%(+3.0%) |
| Sept 2023 | - | 28.31%(+74.1%) |
| June 2023 | - | 16.26%(+130.3%) |
| Mar 2023 | - | 7.06%(-71.9%) |
| Dec 2022 | 16.73%(-8.7%) | 25.10%(+10.9%) |
| Sept 2022 | - | 22.63%(+56.5%) |
| June 2022 | - | 14.46%(+1346.0%) |
| Mar 2022 | - | 1.00%(-95.1%) |
| Dec 2021 | 18.33%(-41.5%) | 20.51%(+36.5%) |
| Sept 2021 | - | 15.03%(-36.0%) |
| June 2021 | - | 23.47%(+76.3%) |
| Mar 2021 | - | 13.31%(-54.0%) |
| Dec 2020 | 31.31%(+8.9%) | 28.96%(+0.9%) |
| Sept 2020 | - | 28.70%(-29.2%) |
| June 2020 | - | 40.54%(+63.2%) |
| Mar 2020 | - | 24.84%(-28.7%) |
| Dec 2019 | 28.75%(+211.8%) | 34.82%(-14.2%) |
| Sept 2019 | - | 40.57%(+89.0%) |
| June 2019 | - | 21.47%(+145.7%) |
| Mar 2019 | - | 8.74%(-56.8%) |
| Dec 2018 | 9.22%(-114.7%) | 20.22%(-43.5%) |
| Sept 2018 | - | 35.80%(-1974.3%) |
| June 2018 | - | -1.91%(-96.4%) |
| Mar 2018 | - | -52.68%(-219.0%) |
| Dec 2017 | -62.71%(-93.6%) | 44.26%(-548.9%) |
| Sept 2017 | - | -9.86%(-98.9%) |
| June 2017 | - | -903.99%(+550.1%) |
| Dec 2016 | -982.48%(+106.2%) | - |
| Mar 2016 | - | -139.05%(+1101.8%) |
| Dec 2015 | -476.51%(-72.0%) | - |
| Mar 2015 | - | -11.57%(-99.3%) |
| Dec 2013 | -1701.88%(<-9900.0%) | -1579.45%(-4.1%) |
| Sept 2013 | - | -1646.91%(-8.7%) |
| June 2013 | - | -1803.70%(+1.5%) |
| Mar 2013 | - | -1777.40%(-4645.8%) |
| Dec 2012 | 2.72%(-93.8%) | 39.10%(-192.3%) |
| Sept 2012 | - | -42.34%(+224.2%) |
| June 2012 | - | -13.06%(-17.9%) |
| Mar 2012 | - | -15.90%(-495.5%) |
| Dec 2011 | 43.82%(-207.0%) | 4.02%(-94.5%) |
| Sept 2011 | - | 73.11%(+710.5%) |
| June 2011 | - | 9.02%(-41.8%) |
| Mar 2011 | - | 15.50%(-1748.9%) |
| Dec 2010 | -40.96%(-97.6%) | -0.94%(-105.5%) |
| Sept 2010 | - | 17.07%(-113.5%) |
| June 2010 | - | -126.86%(-90.6%) |
| Mar 2010 | - | -1350.46%(-18.6%) |
| Dec 2009 | -1730.88% | -1659.59%(+26.3%) |
| Sept 2009 | - | -1314.32%(-35.4%) |
| June 2009 | - | -2033.02%(+6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2009 | - | -1913.79%(-51.3%) |
| Dec 2008 | -2144.58%(-87.6%) | -3931.96%(+90.5%) |
| Sept 2008 | - | -2063.60%(-24.7%) |
| June 2008 | - | -2740.74%(+131.1%) |
| Mar 2008 | - | -1185.72%(-95.1%) |
| Dec 2007 | -17.34 K%(+5903.7%) | -24.17 K%(+352.8%) |
| Sept 2007 | - | -5338.15%(-90.7%) |
| June 2007 | - | -57.39 K%(+118.8%) |
| Mar 2007 | - | -26.23 K%(>+9900.0%) |
| Dec 2006 | -288.82%(+1327.0%) | -172.28%(-95.4%) |
| Sept 2006 | - | -3742.64%(+1082.2%) |
| June 2006 | - | -316.57%(+123.4%) |
| Mar 2006 | - | -141.68%(-18.7%) |
| Dec 2005 | -20.24%(-67.1%) | -174.29%(-549.2%) |
| Sept 2005 | - | 38.80%(-305.8%) |
| June 2005 | - | -18.85%(-88.4%) |
| Mar 2005 | - | -163.07%(+42.3%) |
| Dec 2004 | -61.44%(+45.4%) | -114.60%(+1212.7%) |
| Sept 2004 | - | -8.73%(-90.2%) |
| June 2004 | - | -88.97%(+2.3%) |
| Mar 2004 | - | -86.95%(+35.8%) |
| Dec 2003 | -42.27%(-92.6%) | -64.02%(+38.0%) |
| Sept 2003 | - | -46.39%(+67.0%) |
| June 2003 | - | -27.78%(-31.7%) |
| Mar 2003 | - | -40.70%(-96.2%) |
| Dec 2002 | -574.20%(+439.7%) | -1064.29%(+135.7%) |
| Sept 2002 | - | -451.56%(-13.3%) |
| June 2002 | - | -520.94%(+44.9%) |
| Mar 2002 | - | -359.51%(+199.5%) |
| Dec 2001 | -106.40%(-56.4%) | -120.03%(-2274.5%) |
| Sept 2001 | - | 5.52%(-101.2%) |
| June 2001 | - | -468.51%(+16.1%) |
| Mar 2001 | - | -403.64%(+26.5%) |
| Dec 2000 | -244.04%(+106.0%) | -319.04%(+75.3%) |
| Sept 2000 | - | -181.95%(-27.5%) |
| June 2000 | - | -250.85%(-3.6%) |
| Mar 2000 | - | -260.12%(+118.5%) |
| Dec 1999 | -118.45%(+52.8%) | -119.05%(+23.8%) |
| Sept 1999 | - | -96.15%(-30.8%) |
| June 1999 | - | -138.85%(+11.1%) |
| Mar 1999 | - | -125.00%(+52.0%) |
| Dec 1998 | -77.50%(-4136.5%) | -82.22%(+35.3%) |
| Sept 1998 | - | -60.78%(-58.9%) |
| June 1998 | - | -147.83%(+152.5%) |
| Mar 1998 | - | -58.54%(+179.2%) |
| Dec 1997 | 1.92%(-87.3%) | -20.97%(+225.1%) |
| Sept 1997 | - | -6.45%(-65.6%) |
| June 1997 | - | -18.75%(-152.1%) |
| Mar 1997 | - | 35.96%(+1.4%) |
| Dec 1996 | 15.10% | 35.48%(-152.0%) |
| Sept 1996 | - | -68.18%(-388.4%) |
| June 1996 | - | 23.64%(-360.1%) |
| Mar 1996 | - | -9.09% |
FAQ
- What is Neurocrine Biosciences annual operating profit margin?
- What is the all time high annual operating margin for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual operating margin year-on-year change?
- What is Neurocrine Biosciences quarterly operating profit margin?
- What is the all time high quarterly operating margin for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly operating margin year-on-year change?
What is Neurocrine Biosciences annual operating profit margin?
The current annual operating margin of NBIX is 20.92%
What is the all time high annual operating margin for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual operating profit margin is 43.82%
What is Neurocrine Biosciences annual operating margin year-on-year change?
Over the past year, NBIX annual operating profit margin has changed by +4.19% (+25.04%)
What is Neurocrine Biosciences quarterly operating profit margin?
The current quarterly operating margin of NBIX is 29.71%
What is the all time high quarterly operating margin for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly operating profit margin is 73.11%
What is Neurocrine Biosciences quarterly operating margin year-on-year change?
Over the past year, NBIX quarterly operating profit margin has changed by +1.40% (+4.95%)